Research progress on multivalent genetically engineered vaccines against enterotoxigenic Escherichia coli

Area of Science:

• Veterinary Microbiology
• Infectious Diseases
• Bacteriology

Background:

• Enterotoxigenic Escherichia coli (ETEC) is a primary cause of bacterial diarrhea in young animals.
• ETEC pathogenicity is linked to specific adhesins and enterotoxins, with significant serotype diversity influencing virulence.
• Understanding ETEC's host susceptibility and transmission routes is crucial for effective control.

Purpose of the Study:

• To systematically review the etiology, epidemiology, and control of ETEC-induced diarrhea in animals.
• To analyze ETEC serotype diversity, pathogenicity, and host-specific susceptibility.
• To evaluate current prevention strategies, focusing on vaccination against ETEC.

Main Methods:

• Systematic literature review of ETEC etiological characteristics and epidemiology.
• Analysis of ETEC transmission pathways via contaminated food and water.
• Review of current prevention and control strategies, emphasizing vaccination efficacy and vaccine development.

Main Results:

• ETEC exhibits diverse serotypes and pathogenicity factors, with varying susceptibility across animal hosts and age groups.
• Contaminated water and food are key epidemiological features for ETEC transmission.
• Vaccination is identified as the most effective control strategy due to widespread antibiotic resistance.

Conclusions:

• ETEC poses a significant threat to animal health, necessitating advanced control measures.
• Research into multivalent, genetically engineered, and live-vector vaccines targeting ETEC antigens shows promising application potential.
• Developing broad-spectrum vaccines is essential for mitigating ETEC-related diarrhea and addressing antibiotic resistance.